Picture of Intra-Cellular Therapies logo

ITCI — Intra-Cellular Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results

Aug 9 (Reuters) - Intra-Cellular Therapies Inc  ITCI.O :
    * INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 REVENUE ROSE 178 PERCENT TO $55.6 MILLION
    * QTRLY NET LOSS PER COMMON SHARE: BASIC & DILUTED $0.92

Source text for Eikon:  ID:nGNX6bbVgL 
Further company coverage:  ITCI.O

Recent news on Intra-Cellular Therapies

See all news